Quarterly Activities/Appendix 4C Cash Flow Report

BPH Global Limited (ASX: BP8) (“BP8” or the “Company” or the “Group”), a plant-based biotechnology company, today released its Appendix 4C and Quarterly Activities Report for the period ended 31 March 2024.

Corporate activities

BP8 ended the quarter with cash of approximately $0.257 million ($0.367 million at 31 December 2023).

On 23 April 2024, the Company issued a notice of general meeting to be convened on 24 April 2024 (Notice of Meeting) at which the Company will seek shareholder approval pursuant to ASX Listing Rule 7.1 to undertake a share placement to sophisticated and professional investors. The share placement authority is for the Company to raise up to $1,000,000. Further details regarding the proposed share placement can be found in the Notice of Meeting.

Total aggregate cash payments of $56,000 were made during the quarter to related parties and their associates as remuneration. Details of these payments are included in items 6 of the Appendix 4C.

Renewal of China Tobacco Sales and Distribution Agreements

Following the Company’s acquisition of Foshan Gedishi Biotechnology Co Ltd (Foshan) in the December quarter, the Company announced on 6 February 2024 the renewal of the two (2) sales and distribution agreements from 2023 between the Company’s now wholly owned subsidiary Foshan and two (2) wholly owned subsidiaries of China Tobacco based in Guangzhou City in the Province of Guangdong (2023 Agreements). The two wholly owned subsidiaries are Guangzhou Gold Leaves Franchise Co Ltd (Golden Leaves) and Guangzhou City Twenty Sticks Commercial Franchise Co Ltd (Twenty Sticks).

The principal terms of the 2024 Agreements include:

• commencement date 1 January 2024;
• term 12 months;
• products to be supplied:
  • pure bird’s nest 50g box;
  • pure bird’s nest 100g box; and
  • bird’s nest drink - each box contains 3 bottles with 1.5g bird nest content; and
• products to be sold in China Tobacco outlets in the Guangzhou Province of China.

Initial sales results

Foshan commenced its sales of bird’s nest products as the Company’s wholly owned subsidiary in early January 2024 in the lead up to Chinese (Lunar) New Year (which commenced in early February 2024).

Click here for the full ASX Release

This article includes content from BPH Global Ltd, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.